Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

NIVESTYM™ Principal Display Panel (filgrastim-aafi)

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label

1 mL Single-Dose Vial

Nivestym™
(filgrastim-aafi)
Injection

300 mcg/mL

Mfd. by Hospira, Inc., a Pfizer Company,
Lake Forest, IL 60045 USA US License No. 1974

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label

PRINCIPAL DISPLAY PANEL - 1 mL Vial Carton

10 x 300 mcg/mL
Single-Dose Vials (containing 1 mL)
Discard unused portion

NDC 0069-0293-10
Rx Only

Pfizer

Nivestym™
(filgrastim-aafi) Injection

300 mcg/mL

For Intravenous or
Subcutaneous Use Only

Sterile Solution -
No Preservative

A recombinant Granulocyte Colony Stimulating Factor (rG-CSF) derived from E. coli

PRINCIPAL DISPLAY PANEL - 1 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 1.6 mL Vial Label

1.6 mL Single-Dose Vial

Nivestym™
(filgrastim-aafi)
Injection

480 mcg/1.6 mL

Mfd. by Hospira, Inc., a Pfizer Company,
Lake Forest, IL 60045 USA US License No. 1974

PRINCIPAL DISPLAY PANEL - 1.6 mL Vial Label

PRINCIPAL DISPLAY PANEL - 1.6 mL Vial Carton

10 x 480 mcg/1.6 mL
Single-Dose Vials (containing 1.6 mL)
Discard unused portion

NDC 0069-0294-10
Rx Only

Pfizer

Nivestym™
(filgrastim-aafi) Injection

480 mcg/1.6 mL

For Intravenous or
Subcutaneous Use Only

Sterile Solution -
No Preservative

A recombinant Granulocyte Colony Stimulating Factor (rG-CSF) derived from E. coli

PRINCIPAL DISPLAY PANEL - 1.6 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label

Nivestym™
(filgrastim-aafi) Injection

NDC 0069-0292-01
Rx Only
For Subcutaneous Use Only
Mfd by Hospira Inc, a Pfizer Company,
Lake Forest, IL 60045 USA

300 mcg/0.5 mL

Single-Dose Prefilled Syringe with
Needle Guard

US License No. 1974

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Carton - 2431

Pfizer

Nivestym™
(filgrastim-aafi) Injection

1 x 300 mcg/0.5 mL
Single-Dose Prefilled Syringe
with Needle Guard
Discard unused portion.

NDC 0069-0291-01
Rx Only

A recombinant Granulocyte Colony Stimulating
Factor (rG-CSF) derived from E. coli

300 mcg/0.5 mL

Refrigerate at 2° to 8°C (36° to 46°F).
Do Not Freeze or Shake. Protect from light.

The syringe plunger stopper and needle cover
are not made with natural rubber latex.

Subcutaneous Use Only
Sterile Solution - No Preservative

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Carton - 2431

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Carton - 2433

Pfizer

Nivestym™
(filgrastim-aafi) Injection

300 mcg/0.5 mL

1 x 300 mcg/0.5 mL
Single-Dose Prefilled Syringe with Needle Guard
Discard unused portion.

NDC 0069-0291-01
Rx Only

A recombinant Granulocyte Colony Stimulating
Factor (rG-CSF) derived from E. coli

Subcutaneous Use Only
Sterile Solution - No Preservative

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Carton - 2433

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Carton - 2434

10 x 300 mcg/0.5 mL
Single-Dose Prefilled Syringe with Needle Guard
Discard unused portion.

NDC 0069-0291-10
Rx Only

Pfizer

Nivestym™
(filgrastim-aafi) Injection

300 mcg/0.5 mL

A recombinant Granulocyte Colony Stimulating
Factor (rG-CSF) derived from E. coli

Subcutaneous Use Only
Sterile Solution - No Preservative

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Carton - 2434

PRINCIPAL DISPLAY PANEL - 0.8 mL Syringe Label

Nivestym™
(filgrastim-aafi) Injection

NDC 0069-0291-01
Rx Only
For Subcutaneous Use Only
Mfd by Hospira Inc, a Pfizer Company,
Lake Forest, IL 60045 USA

480 mcg/0.8 mL

Single-Dose Prefilled Syringe with
Needle Guard

US License No. 1974

PRINCIPAL DISPLAY PANEL - 0.8 mL Syringe Label

PRINCIPAL DISPLAY PANEL - 0.8 mL Sryinge Carton - 2432

Pfizer

Nivestym™
(filgrastim-aafi) Injection

1 x 480 mcg/0.8 mL
Single-Dose Prefilled Syringe
with Needle Guard
Discard unused portion.

NDC 0069-0292-01
Rx Only

A recombinant Granulocyte Colony Stimulating
Factor (rG-CSF) derived from E. coli

480 mcg/0.8 mL

Subcutaneous Use Only
Sterile Solution - No Preservative

Refrigerate at 2° to 8°C (36° to 46°F).
Do Not Freeze or Shake. Protect from light.

The syringe plunger
stopper and needle
cover are not made with
natural rubber latex.

PRINCIPAL DISPLAY PANEL - 0.8 mL Sryinge Carton - 2432

PRINCIPAL DISPLAY PANEL - 0.8 mL Sryinge Carton - 2435

Pfizer

Nivestym™
(filgrastim-aafi) Injection

1 x 480 mcg/0.8 mL
Single-Dose Prefilled Syringe with Needle Guard
Discard unused portion.

NDC 0069-0292-01
Rx Only

480 mcg/0.8 mL

A recombinant Granulocyte Colony Stimulating
Factor (rG-CSF) derived from E. coli

Subcutaneous Use Only
Sterile Solution - No Preservative

PRINCIPAL DISPLAY PANEL - 0.8 mL Sryinge Carton - 2435

PRINCIPAL DISPLAY PANEL - 0.8 mL Sryinge Carton - 2436

10 x 480 mcg/0.8 mL
Single-Dose Prefilled Syringe with Needle Guard
Discard unused portion.

NDC 0069-0292-10
Rx Only

Pfizer

Nivestym™
(filgrastim-aafi) Injection

480 mcg/0.8 mL

A recombinant Granulocyte Colony Stimulating
Factor (rG-CSF) derived from E. coli

Subcutaneous Use Only
Sterile Solution - No Preservative

PRINCIPAL DISPLAY PANEL - 0.8 mL Sryinge Carton - 2436
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch